1. Ergonul O (2007) Clinical and Pathologic Features of Crimean Congo Hemorrhagic Fever. İn: Ergonul O, Whitehouse CA (Eds): Crimean Congo Hemorrhagic Fever: A Global Perspective, Vol.1. Dordrecht (NL): Springer, pp. 207–220.
2. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B (2006) Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 12(6): 551–554.
3. Zeller H (2007) Laboratory Diagnosis of Crimean Congo Hemorrhagic Fever. İn: Ergonul O, Whitehouse CA (Eds): Crimean Congo Hemorrhagic Fever: A Global Perspective. Vol. 1. Dordrecht (NL): Springer, pp. 233–243.
4. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S (1989) The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 11(Suppl 4): 794–800.
5. Leblebicioğlu H, Sümbül M, Memish ZA, Al-Tawfik JA, Bodur H, Özkul A, Gücükoğlu A, Chinikar S, Hasan Z (2015) Consensus report: Preventive measures for Crimean-Congo Hemorrhagic Fever during Eid-al-Adha festival. Int J Infect Dis. 38: 9–15.
6. Whitehouse CA (2007) Risk Groups and Control Measures for Crimean Congo Hemorrhagic Fever. In: Ergonul O, White-house CA (Eds): Crimean-Congo Hemorrhagic Fever: A Global Perspective. Vol. 1. Dordrecht (NL): Springer, pp. 273–280.
7. Arslan M, Yılmaz G, Menteşe A, Yılmaz H, KarahaN SC, Köksal I (2017) Importance of endothelial dysfunction bio-markers in patients with Crimean-Congo hemorrhagic fever. J Med Virol. 89(12): 2084–2091.
8. Ergonul O (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 6(4): 203–214.
9. Whitehouse CA (2007) Risk Groups and Control Measures for Crimean Congo Hemorrhagic Fever. In: Ergonul O, Whitehouse CA (Eds): Crimean-Congo Hemorrhagic Fever: A Global Perspective. Vol. 1. Dordrecht (NL): Springer, pp. 273–280.
10. Rasikh AS, Aram MM, Noory AT (2023) Clinical and epidemiological characteristics of 30 fatal cases of Crimean-Congo hemorrhagic fever in Kabul, Afghanistan: a retrospective observational study. Infect Drug Resist. 16: 3469–3476.
11. Bastug A, Kayaaslan B, Kazancioglu S, Aslaner H, But A, Akinci E, Yetkin MA, Eren S, Bodur H (2016) Crimean-Congo Hemorrhagic Fever: Prognostic Factors and the Association of Leukocyte Counts with Mortality. Jpn J Infect Dis. 69(1): 51–55.
12. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, And The Turkish Cchf Study Group (2005) Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multi-centre study of clinical features and outcome measures. J Med Microbiol. 54(Pt 4): 385–389.
13. Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, Sohail MR, Mahmood SF, Ochani R, Hussham Arshad M, Kumar A, Surani S (2021) COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 29(1): 20–36.
14. Pazarlı AC, Parlak Z, Ekiz T (2020) COVID-19 and Crimean-Congo Hemorrhagic Fever: Similarities and Differences. Heart Lung. 49(6): 892–893.